SF-12 MCS score at baseline | Multiple linear regression (adjusted R2=0.33) | Stepwise regression (adjusted R2=0.35) | ||
β (95% CI) | P value | β (95% CI) | P value | |
Age | 1.01 (0.45 to 1.57) | 0.00 | 0.83 (0.35 to 1.32) | <0.01 |
Female | −2.09 (−5.86 to 1.69) | 0.28 | ||
BMI | −0.05 (−0.43 to 0.33) | 0.79 | ||
Medical history | ||||
Hypertension | 1.85 (−1.78 to 5.49) | 0.31 | ||
Diabetes mellitus | −4.03 (−8.07 to to 0.01) | 0.05 | −2.74 (−6.34 to 0.89) | 0.03 |
Previous MI | 2.90 (−1.90 to 7.71) | 0.23 | ||
Previous PCI | −1.87 (−6.42 to 2.68) | 0.42 | ||
Baseline CCS class | ||||
No angina | 0.00 | 0.52 | ||
Class I | 3.14 (−4.53 to 10.81) | |||
Class II | 3.07 (−3.64 to 9.77) | |||
Class III | 0.03 (−6.39 to 6.45) | |||
Class IV | 4.76 (−4.93 to 14.46) | |||
Baseline NYHA class | ||||
Class I | 0.00 | 0.07 | 0.00 | 0.20 |
Class II | 0.93 (−5.68 to 7.54) | 1.23 (−4.85 to 7.30) | ||
Class III | 6.29 (−1.16 to 13.74) | 4.78 (−2.05 to 11.62) | ||
Class IV | 2.73 (−7.90 to 13.35) | 0.15 (−9.41 to 9.71) | ||
Charlson comorbidity score | −0.69 (−1.72 to 0.34) | 0.19 | −0.47 (−1.26 to 0.31) | 0.24 |
GRACE 1-year mortality | −0.08 (−0.25 to 0.92) | 0.37 | ||
EuroScore II | −0.10 (−0.59 to 0.40) | 0.70 | ||
Clinical presentation | ||||
Stable angina | 0.00 | 0.60 | ||
Unstable angina | 0.70 (−4.91 to 6.31) | |||
NSTEMI | 0.27 (−4.37 to 4.91) | |||
STEMI | −5.86 (−15.8 to 4.07) | |||
Fried score | ||||
Not frail | 0.00 | 0.77 | ||
Pre-frail | −1.70 (−6.87 to 3.47) | |||
Frail | −0.94 (−7.63 to 5.75) | |||
Edmonton frailty score | ||||
Not frail | 0.00 | 0.00 | 0.00 | <0.01 |
Vulnerable | −11.45 (−15.7 to 7.1) | −11.23 (−15.11 to 7.35) | ||
Mild frailty | −4.85 (−10.38 to 0.69) | −5.88 (−10.91 to 0.85) | ||
Moderate frailty | −14.25 (−21.19 to 7.31) | −14.13 (−20.29 to 7.96) | ||
Severe frailty | −21.63 (−31.0 to 12.24) | −22.05 (−29.52 to 14.5) |